Gustavo Hirata Dellavia

Gustavo Hirata Dellavia

Auto-generated profile, based on publicly available information

Gustavo Hirata Dellavia

School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Clinical and Experimental Gastroenterology
Verified
Journal Article
Open access
PDF file
LLLarisse Longo
Larisse Longo
JFJéssica Tonin Ferrari
Jéssica Tonin Ferrari
Pabulo Henrique RampelottoPabulo Henrique Rampelotto
Pabulo Henrique Rampelotto
GDGustavo Hirata Dellavia
Gustavo Hirata Dellavia
APAmanda Pasqualotto
Amanda Pasqualotto
MAMario Reis Alvares-da-Silva
Mario Reis Alvares-da-Silva
Background/Aim: The interactions between the gut and liver have been described in the progression of non-alcoholic steatohepatitis (NASH). The aim of this study was to develop an experimental nutritional model of NASH simulating metabolic changes occurring in humans. Materials and Methods: Adult male Sprague Dawley rats were randomized into two groups: controls (standard diet) and intervention (high-fat and choline-deficient diet) for 16 weeks, each experimental group with 10 animals. Biochemical analysis, hepatic lipid content, microRNAs, inflammatory, gut permeability markers and gut microbiota were measured. Results: Animals in the intervention group showed significantly higher delta Lee index (p=0.017), abdominal circumference (p< 0.001), abdominal adipose tissue (p< 0.001) and fresh liver weight (p< 0.001), as well as higher serum levels of alanine aminotransferase (p=0.010), glucose (p=0.013), total cholesterol (p=0.033), LDL cholesterol (p=0.011), and triglycerides (p=0.011), and lower HDL cholesterol (p=0.006) compared to the control group. Higher TLR4 (p=0.041), TLR9 (p=0.033), MyD88 (p=0.001), Casp1 (p< 0.001), NLPR3 (p=0.019), liver inflammation index interleukin (IL)-1β/IL10 (p< 0.001), IL6/IL10 (p=0.002) and TNFα/IL10 (p=0.001) were observed in the intervention group, and also lower permeability markers Ocln (p=0.003) and F11r (p=0.041). Gene expression of miR-122 increased (p=0.041) and miR-145 (p=0.010) decreased in the intervention group. Liver steatosis, inflammation and fibrosis, along with collagen fiber deposition increment (p< 0.001), were seen in the intervention group. Regarding gut microbiota, Bray-Curtis dissimilarity index and number of operational taxonomic units were significantly different (p< 0.001) between the groups. Composition of the gut microbiota showed a significant correlation with histopathological score of NAFLD (r=0.694) and index IL-1β/IL-10 (r=0.522). Conclusion: This experimental model mimicking human NASH demonstrated gut and liver interaction, with gut microbiota and intestinal permeability changes occurring in parallel with systemic and liver inflammation, miRNAs regulation and liver tissue damage.

1 October 2020 in Clinical and Experimental Gastroenterology
Verified
Journal Article
Open access
PDF file
LLLarisse Longo
Larisse Longo
JFJéssica Tonin Ferrari
Jéssica Tonin Ferrari
Pabulo Henrique RampelottoPabulo Henrique Rampelotto
Pabulo Henrique Rampelotto
GDGustavo Hirata Dellavia
Gustavo Hirata Dellavia
APAmanda Pasqualotto
Amanda Pasqualotto
MAMario Reis Alvares-da-Silva
Mario Reis Alvares-da-Silva
Gut Dysbiosis and Increased Intestinal Permeability Drive microRNAs, NLRP-3 Inflammasome and Liver Fibrosis in a Nutritional Model of Non-Alcoholic Steatohepatitis in Adult Male Sprague Dawley Rats [Erratum]